EFFECTS OF 3 GENETIC-LOCI IN A PEDIGREE WITH MULTIPLE LIPOPROTEIN PHENOTYPES

被引:28
作者
EMI, M
HEGELE, RM
HOPKINS, PN
WU, LL
PLAETKE, R
WILLIAMS, RR
LALOUEL, JM
机构
[1] UNIV UTAH,HLTH SCI CTR,HOWARD HUGHES MED INST,ECCLES INST HUMAN GENET,SUITE 6200,SALT LAKE CITY,UT 84112
[2] UNIV UTAH,CARDIOVASC GENET RES CLIN,SALT LAKE CITY,UT 84112
来源
ARTERIOSCLEROSIS AND THROMBOSIS | 1991年 / 11卷 / 05期
关键词
LINKAGE ANALYSIS; TYPE-IIA HYPERLIPOPROTEINEMIA; LOW DENSITY LIPOPROTEIN RECEPTOR DEFECT; PEDIGREE ANALYSIS;
D O I
10.1161/01.ATV.11.5.1349
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In the course of familial investigations of coronary artery disease, we identified an extended kinship in which several members were affected with type IIa hyperlipoproteinemia (HLPIIa), type III dyslipoproteinemia (DLPIII), or hypobetalipoproteinemia (HBLP). To study the genetic defects responsible for plasma lipoprotein abnormalities in this pedigree and to investigate the phenotypic effect of different genotypic combinations, we used molecular markers for apolipoprotein (apo) B, apo E, and the low density lipoprotein (LDL) receptor to characterize segregation at each locus. Linkage analysis showed that elevated LDL cholesterol levels and the HBLP phenotype were due to defects at the LDL receptor and the apo B loci, respectively. One pedigree member, who inherited both an LDL receptor allele linked with elevated LDL cholesterol levels and an apo B allele linked with HBLP, had a normal lipoprotein phenotype. Seven patients who simultaneously inherited the defective LDL receptor allele and one or two apo E2 alleles manifested DLPIII. The E2 alleles in this pedigree were shown by DNA sequence analysis to be the common E2 158(arginine --> cysteine) allele. These findings suggested a possible interaction between the abnormal LDL receptor and apo E2 alleles, resulting in the expression of DLPIII in the presence of a single copy of apo E2.
引用
收藏
页码:1349 / 1355
页数:7
相关论文
共 31 条
[1]   GENETIC-REGULATION OF APOLIPOPROTEINS [J].
BRESLOW, JL .
AMERICAN HEART JOURNAL, 1987, 113 (02) :422-427
[2]  
BRESLOW JL, 1982, J LIPID RES, V23, P1224
[3]  
CAVENEE W, 1984, AM J HUM GENET, V36, P10
[4]   GENETIC-LINKAGE BETWEEN LIPOPROTEIN(A) PHENOTYPE AND A DNA POLYMORPHISM IN THE PLASMINOGEN GENE [J].
DRAYNA, DT ;
HEGELE, RA ;
HASS, PE ;
EMI, M ;
WU, LL ;
EATON, DL ;
LAWN, RM ;
WILLIAMS, RR ;
WHITE, RL ;
LALOUEL, JM .
GENOMICS, 1988, 3 (03) :230-236
[5]   GENOTYPING AND SEQUENCE-ANALYSIS OF APOLIPOPROTEIN-E ISOFORMS [J].
EMI, M ;
WU, LL ;
ROBERTSON, MA ;
MYERS, RL ;
HEGELE, RA ;
WILLIAMS, RR ;
WHITE, R ;
LALOUEL, JM .
GENOMICS, 1988, 3 (04) :373-379
[6]   TYPE-III HYPERLIPOPROTEINEMIA - ANALYSIS OF 2 CONTEMPORARY DEFINITIONS [J].
FREDRICKSON, DS ;
MORGANROTH, J ;
LEVY, RI .
ANNALS OF INTERNAL MEDICINE, 1975, 82 (02) :150-157
[7]   DOUBLE MSP-I RFLP IN THE HUMAN LDL RECEPTOR GENE [J].
GEISEL, J ;
WEISSHAAR, B ;
OETTE, K ;
MECHTEL, M ;
DOERFLER, W .
NUCLEIC ACIDS RESEARCH, 1987, 15 (09) :3943-3943
[8]  
Goldstein J.L., 1989, METABOLIC BASIS INHE, P1215
[9]   HYPERLIPIDEMIA IN CORONARY HEART-DISEASE .2. GENETIC ANALYSIS OF LIPID-LEVELS IN 176 FAMILIES AND DELINEATION OF A NEW INHERITED DISORDER, COMBINED HYPERLIPIDEMIA [J].
GOLDSTEIN, JL ;
SCHROTT, HG ;
HAZZARD, WR ;
BIRMAN, EL ;
MOTULSKY, AG .
JOURNAL OF CLINICAL INVESTIGATION, 1973, 52 (07) :1544-1568
[10]   APOLIPOPROTEIN E3-LEIDEN - A NEW VARIANT OF HUMAN APOLIPOPROTEIN-E ASSOCIATED WITH FAMILIAL TYPE-3 HYPERLIPOPROTEINEMIA [J].
HAVEKES, L ;
DEWIT, E ;
LEUVEN, JG ;
KLASEN, E ;
UTERMANN, G ;
WEBER, W ;
BEISIEGEL, U .
HUMAN GENETICS, 1986, 73 (02) :157-163